Representative before the EPO

Employment test 11 - 50 employees
Company dna elkington and fife llp
operating since 1927
Headquarter in London and 3 offices
active in Legal Services and IP Consulting

We have observed 48 EP applications Richard Edward Gillard has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 02, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12718318

A DEVICE FOR DETECTING AN ANALYTE

IPC classification:
G01N 33/543, G01N 33/542, G01N 29/24, G01N 21/17
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP11865208

METHOD FOR TREATING PROSTATE CANCER

IPC classification:
A61K 36/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12817817

CYSTEINE PRODRUGS

IPC classification:
A61K 31/426, C07D 277/14, A61P 25/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12823540

SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS

IPC classification:
A01N 37/36, C07C 243/00, C07C 241/00
Applicant:
University of Utah Research Foundation
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13003519

Novel polymorphic forms of perindopril (L)-arginine and process for the preparation thereof

IPC classification:
A61K 31/404, C07D 209/42, A61P 9/12
Agent:
Alexander Wittkopp, Maiwald Patentanwalts GmbH
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
The patent has been granted
EP12853818

SINGLE MODE MICROWAVE DEVICE FOR PRODUCING EXFOLIATED GRAPHITE

IPC classification:
C01B 31/04, B01J 19/12
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP12810409

METHOD AND DEVICE FOR MEASURING COAGULATION IN A SAMPLE OF A BLOOD PRODUCT

IPC classification:
G01N 33/86, G01N 33/49, G01N 29/24, G01N 29/02, G01N 25/48, G01N 21/82, G01N 21/17, G01N 15/05, B82Y 15/00, B01L 3/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12806382

AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

IPC classification:
A61K 31/46, A61K 9/12, A61K 9/00, A61P 11/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva Global Patent Group
Status:
PATENT GRANTED
EP12805442

AN INHALER COMPRISING A TIOTROPIUM-CONTAINING-COMPOSITION

IPC classification:
A61K 31/46, A61K 9/12, A61P 11/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
David William Cottam, Teva UK Ltd.
Agent:
David William Cottam, Teva Global Patent Group
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
The patent has been granted
EP12779275

TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE THEREOF

IPC classification:
A61K 47/38, A61K 47/22, A61K 47/20, A61K 47/18, A61K 47/14, A61K 47/10, A61K 31/192, A61P 29/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
Multiple attorneys, Fish & Richardson PC
Status:
EXAMINATION IN PROGRESS
EP12766194

COMPOSITIONS AND METHODS FOR TREATMENT OF GLAUCOMA

IPC classification:
A61K 47/10, A61K 9/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION WITHDRAWN
EP13746990

BLAST TREATMENT METHOD

IPC classification:
F42D 5/04, F42B 33/06, B30B 5/00, B21J 5/06
Applicant:
Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel Ltd)
Agent:
Multiple attorneys, Elkington and Fife LLP
Status:
PATENT GRANTED
EP13726306

AN IMPROVED PROCESS FOR THE PREPARATION OF ALISKIREN

IPC classification:
C07C 231/22, C07C 231/12
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14001800

Heat sterilization of glucocorticoidsteriods

IPC classification:
A61K 9/10
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva Global Patent Group
Status:
The patent has been granted
EP14158985

Amorphous rotigotine transdermal system

IPC classification:
A61K 31/381, A61K 9/70
Agent:
Christopher K. Hamer, Mathys & Squire LLP
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP13718030

AN ASSAY LABEL

IPC classification:
G01N 33/58, G01N 33/548, G01N 33/543
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14809248

AN INHALABLE MEDICAMENT

IPC classification:
A61K 9/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP14809570

AN INHALABLE MEDICAMENT

IPC classification:
A61K 9/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
The patent has been granted
EP13844898

COMBINATION DRUG COMPRISING GEMIGLIPTIN AND METFORMIN, AND METHOD FOR THE PREPARATION THEREOF

IPC classification:
A61K 31/155, A61K 9/24, A61K 9/20
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13852301

THIOARYL DERIVATIVES AS GPR120 AGONISTS

IPC classification:
A61K 31/44, C07D 241/18, C07D 213/80, A61P 3/10
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13852767

GPR40 RECEPTOR AGONIST, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT

IPC classification:
A61K 31/404, C07D 409/04, C07D 209/22, A61P 3/10
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13859129

AUTOMATIC IN VITRO DIAGNOSTIC APPARATUS INCLUDING INCLINED ROTATING PLATE

IPC classification:
G01N 37/00, G01N 33/53, G01N 33/52, G01N 21/78
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15161261

PROPIONIC ACIDS, PROPIONIC ACID ESTERS, AND RELATED COMPOUNDS

IPC classification:
A61K 31/195, C07D 309/02, C07D 211/80, C07C 323/57, A61P 25/18
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP14746632

PPAR AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS

IPC classification:
A61K 31/47, A61P 25/00
Agent:
John Conroy, Fish & Richardson PC
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP14778370

MICRONIZED PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 9/14
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
Hoffmann Eitle PartmbB
Status:
EXAMINATION REQUESTED
EP14764870

COMPLEX PREPARATION INCLUDING VALSARTAN AND ROSUVASTATIN CALCIUM AND MANUFACTURING METHOD THEREFOR

IPC classification:
A61P 3/00, A61P 3/06, A61K 31/505, A61K 31/41
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14791773

INTERMEDIATE CONNECTOR

IPC classification:
B29C 45/76
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14831578

PROCESS FOR PRODUCING WATER-ABSORBING RESIN PARTICLE

IPC classification:
C08L 101/14, C08K 5/10, C08F 20/00, C08F 2/32
Applicant:
Sumitomo Seika Chemicals Co., Ltd.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP15732545

AEROSOL DEVICE

IPC classification:
A61M 15/08, A61M 15/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP16185402

AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

IPC classification:
A61M 15/00, A61K 47/12, A61K 47/10, A61P 11/00, A61K 9/12, A61K 9/00, A61K 31/46
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP15784372

PROCESS FOR PREPARING A POLYMORPH OF RIVAROXABAN

IPC classification:
C07D 413/14
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP15874145

N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

IPC classification:
A61P 31/18, C07H 19/067, A61P 35/00, A61K 31/7068
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16705611

AN INHALABLE MEDICAMENT

IPC classification:
A61K 31/573, A61K 9/72
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP15890063

FORMULATIONS CONTAINING DIACEREIN AND METHODS OF LOWERING BLOOD LEVELS OF URIC ACID USING THE SAME

IPC classification:
A61K 31/192
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP17195406

HEAT STERILIZATION OF GLUCOCORTICOIDSTERIODS

IPC classification:
A61K 9/10
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16796574

CHOCOLATE SLICE

IPC classification:
A23G 1/30, A23G 1/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16812537

DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES

IPC classification:
C07D 403/06, A61K 31/7072, A61K 31/7064, A61K 31/7068
Applicant:
Columbia University in the City of New York
Applicant:
FundaciĆ³ Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
Agent:
F. R. Kelly & Co.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16815356

THERAPEUTIC USES OF BERBERINE FORMULATIONS

IPC classification:
A61K 31/4745, A61P 31/10
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16818753

DIACEREIN OR RHEIN TOPICAL FORMULATIONS AND USES THEREOF

IPC classification:
A61K 31/235, A61K 31/192
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16831358

ANTHRACENE-9, 10-DIONE DIOXIME COMPOUNDS PRODRUGS AND THEIR USES

IPC classification:
C07C 39/205, A61K 31/18, C07C 15/28
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16837721

USE OF UREIDOMUSTINE (BO-1055) IN CANCER TREATMENT

IPC classification:
A61P 35/02, C07D 219/08, C07D 215/42, C07C 275/42
Applicant:
Memorial Sloan Kettering Cancer Center
Applicant:
Academia Sinica
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16837725

DIACEREIN OR ITS ANALOGS FOR INHIBITING EXPRESSION OF ASC, NLRP3, AND/OR FORMATION OF NLRP3 INFLAMMASOME COMPLEX

IPC classification:
A61K 31/222, A61K 31/192, A61K 31/122, C07C 66/02, C07C 65/34
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16858283

LIQUID SCHOENOCAULON EXTRACT

IPC classification:
A01N 65/08
Applicant:
Mclaughlin Gormley King Company
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16858275

DRY, FLOWABLE SABADILLA EXTRACT

IPC classification:
A01N 65/42, A01N 65/08
Applicant:
Mclaughlin Gormley King Company
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16858278

CONCENTRATED SABADILLA EXTRACT

IPC classification:
A01N 65/42, A01N 65/08
Applicant:
Mclaughlin Gormley King Company
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16858273

SABADILLA OIL

IPC classification:
A01N 65/42, A01N 65/08
Applicant:
Mclaughlin Gormley King Company
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16863016

A PROCESS FOR PROVIDING INORGANIC POLYMER CERAMIC-LIKE MATERIALS

IPC classification:
C09K 8/80, C04B 28/26, C04B 28/00, C04B 35/00, C04B 14/32, C04B 14/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16858280

DE-OILED SABADILLA EXTRACT

IPC classification:
A01N 65/42, A01N 65/08
Applicant:
Mclaughlin Gormley King Company
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made

Please Sign in to use this feature